Revenue: The sum of all revenue fields included for a company's operating activities.
Acumen Pharmaceuticals, Inc. (ABOS) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-32.72M |
|
-- |
|
-- |
|
$32.56M |
|
$-32.56M |
|
$-0.16M |
|
$-32.72M |
|
$-32.72M |
|
$-32.72M |
|
$-32.72M |
|
$-32.72M |
|
$-32.72M |
|
$-32.56M |
|
$-32.70M |
|
72.25M |
|
72.25M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$115.51M |
|
-- |
|
$0.49M |
|
$116.01M |
|
$46.85M |
|
$11.90M |
|
$11.90M |
|
$58.74M |
|
$57.26M |
|
$57.26M |
|
$57.26M |
|
72.31M |
|
| Cash Flow Statement Financials | |
$-42.20M |
|
$12.19M |
|
$35.46M |
|
$54.22M |
|
$59.67M |
|
$5.45M |
|
$4.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
0.17 |
|
0.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.14% |
|
-57.14% |
|
-28.20% |
|
-47.31% |
|
$0.79 |
|
$-0.58 |
|
$-0.58 |
|